Other Stabilizers - Protein Formulation

A Stopped-Flow Kinetic Study of the Assembly of Nonviral Gene Delivery Complexes
A Stopped-Flow Kinetic Study of the Assembly of Nonviral Gene Delivery Complexes April 1, 2005 Chad S. Braun, Mark T. Fisher, Donald A. Tomalia, Gary S. Koe, Janet G. Koe, and C. Russell Middaugh
Clinical and investigational considerations for the use of IGIV therapy
Clinical and investigational considerations for the use of IGIV therapy Aug 2005 Mark Ballow American Journal of Health-System Pharmacy Purpose. Clinical uses of immunoglobulin intravenous (IGIV
Controlling the protein dynamical transition with sugar-based bioprotectant matrices. A neutron scattering study
Controlling the protein dynamical transition with sugar-based bioprotectant matrices. A neutron scattering study April 14, 2006 elena cornicchi, matteo marconi, Giuseppe Onori, and Alessandro Pac
Fast Dynamics and Stabilization of Proteins: Binary Glasses of Trehalose and Glycerol
Fast Dynamics and Stabilization of Proteins: Binary Glasses of Trehalose and Glycerol 2004 Marcus T. Cicerone and Christopher L. Soles Biophysical Journal ABSTRACT We present elastic and
HIV update: emerging clinical evidence and a review of recommendations for the use of highly active antiretroviral therapy
HIV update: emerging clinical evidence and a review of recommendations for the use of highly active antiretroviral therapy Oct 2004 KD Kress American Journal of Health-System Pharmacy PURPOSE: T
Insulin Loaded Eudragit L100 Microspheres for Oral Delivery: Preliminary in vitro Studies
Insulin Loaded Eudragit L100 Microspheres for Oral Delivery: Preliminary in vitro Studies Jan 2006 Deepti Jain, D.K. Majumdar, and A. K. Panda Journal of Biomaterials Applications Abstract Eud
Phase I Comparability of Recombinant Human Albumin and Human Serum Albumin
PHARMACOKINETICS AND PHARMACODYNAMICS: Phase I Comparability of Recombinant Human Albumin and Human Serum Albumin J. Clin. Pharmacol., Jan 2005 Dietrich Bosse, Michaela Praus, Peter Kiessling, Lar
Preparation and Characterization of Chitosan and Trimethyl-chitosan-modified Poly-(e-caprolactone) Nanoparticles as DNA Carriers
Preparation and Characterization of Chitosan and Trimethyl-chitosan-modified Poly-(e-caprolactone) Nanoparticles as DNA Carriers. . August 10, 2005 Haas J, Ravi Kumar MNV, Borchard G, Bakowsky U,
REPLICATION OF CHIMERIC YELLOW FEVER VIRUS-DENGUE SEROTYPE 1?4 VIRUS VACCINE STRAINS IN DENDRITIC AND HEPATIC CELLS
REPLICATION OF CHIMERIC YELLOW FEVER VIRUS-DENGUE SEROTYPE 1?4 VIRUS VACCINE STRAINS IN DENDRITIC AND HEPATIC CELLS Jan 2005 SAMANTHA BRANDLER, NATHAN BROWN, THOMAS H. ERMAK, FRED MITCHELL, MEGAN
Second Virial Coefficient Studies of Cosolvent-Induced Protein Self-Interaction
Second Virial Coefficient Studies of Cosolvent-Induced Protein Self-Interaction September 30, 2005 Joseph J. Valente, Kusum S. Verma, Mark Cornell Manning, W. William Wilson, and Charles S. Henry
The Effects of Intravenous Lidocaine on Pain During Injection of Medium- and Long-Chain Triglyceride Propofol Emulsions
ANESTHETIC PHARMACOLOGY: The Effects of Intravenous Lidocaine on Pain During Injection of Medium- and Long-Chain Triglyceride Propofol Emulsions Jun 2005 Woon Si Yew, Shin Yuet Chong, Kian Hian T
The Role of Reverse Engineering in the Development of Generic Formulations
The Role of Reverse Engineering in the Development of Generic Formulations Aug 2, 2005 By: Arvind K. Bansal, Vishal Koradia Pharmaceutical Technology The authors propose a decision-t
Transport Numbers in Transdermal Iontophoresis
Transport Numbers in Transdermal Iontophoresis January 27, 2006 Blaise Mudry, Richard H. Guy, and M. Bego?a Delgado-Charro Biophysical Journal Abstract: Parameters determining ionic transport